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Originality-Significance Statement 
Clostridioides (Clostridium) difficile is a leading cause of nosocomial antibiotic-associated 
diarrhea, and symptoms of C. difficile infection (CDI) range from mild diarrhea to 
pseudomembranous colitis. However, many aspects of C. difficile physiology and virulence 
remain unclear, particularly the mechanisms of C. difficile colonization in the gut. Here, we 
characterized the surface protein Cwp22 in C. difficile R20291 and found that Cwp22 was 
involved in cell wall integrity and permeability, and affected C. difficile adhesion and 
pathogenesis. Our data suggest that Cwp22 is an attractive target for C. difficile vaccine 
development. 
Summary 
C. difficile is a Gram-positive, spore-forming, toxin-producing anaerobe pathogen, and can 
induce nosocomial antibiotic-associated intestinal disease. While production of toxin A (TcdA) 
and toxin B (TcdB) contribute to the main pathogenesis of C. difficile, adhesion and colonization 
of C. difficile in the host gut are prerequisites for disease onset. Previous cell wall proteins 
(CWPs) were identified that were implicated in C. difficile adhesion and colonization. In this 
study, we predicted and characterized Cwp22 (CDR20291_2601) from C. difficile R20291 to be 
involved in bacterial adhesion based on the Vaxign reverse vaccinology tool. The ClosTron-
generated cwp22 mutant showed decreased TcdA and TcdB production during early growth, and 
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increased cell permeability and autolysis. Importantly, the cwp22 mutation impaired cellular 
adherence in vitro, decreased cytotoxicity and fitness over the parent strain in a mouse infection 
model. Furthermore, LDH cytotoxicity assay, live-dead cell staining and transmission electron 
microscopy (TEM) confirmed the decreased cell viability of the cwp22 mutant. Thus, Cwp22 is 
involved in cell wall integrity and cell viability, which could affect most phenotypes of R20291. 
Our data suggest that Cwp22 is an attractive target for CDI therapeutics and prophylactics. 
Introduction 
Clostridioides difficile (formerly Clostridium difficile) (Lawson et al., 2016; Oren and Garrity, 
2018) is a Gram-positive, spore-forming, toxin-producing, anaerobic bacterium that has 
established itself as a leading cause of nosocomial antibiotic-associated diarrhea in developed 
countries (Sebaihia et al., 2006). Symptoms of C. difficile infection (CDI) range from mild 
diarrhea, intestinal inflammation to pseudomembranous colitis (Lessa et al., 2012). Recently, 
morbidity and mortality rates of CDI have been increasing steadily, causing over 500,000 
infections per year in the United States alone with an estimated cost of $1-3 billion (Dubberke 
and Olsen, 2012; Lessa et al., 2015). 
C. difficile has a number of virulence factors. Among them are two large potent exotoxins, 
toxin A (TcdA) and toxin B (TcdB) that are recognized as the major virulence factors of C. 
difficile (Lyras et al., 2009; Kuehne et al., 2010). These toxins can disrupt the actin cytoskeleton 
of intestinal epithelial cells through glucosylation of the Rho family of GTPases to induce 
mucosal inflammation and the symptoms associated with CDI (Peniche et al., 2013). Other 
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important virulence traits that impact host infection and colonization include: (i) cell wall 
proteins (CWPs) (Biazzo et al., 2013); (ii) tissue degradative proteases (Seddon et al., 1990; 
Seddon and Borriello, 1992; Borriello, 1995); (iii) flagella and fimbriae (Edwards et al., 2000; 
Stevenson et al., 2015; Lorenz et al., 2019).  
To date, 29 CWP-coding genes have been identified in C. difficile. The family of CWPs 
play an important role in composing the outer layer of the bacterial cell, and are likely to be 
involved in C. difficile colonization and pathogenesis (Biazzo et al., 2013; Bradshaw et al., 2018). 
In the family of CWPs, 12 of 29 CWP-coding genes are clustered in the same region, named 
after the S-layer protein (SlpA) coding gene slpA (Cwp1), whereas the remaining 17 coding 
genes are distributed throughout the genome (Bradshaw et al., 2018). Among them, SlpA is an 
abundant protein that was first studied. The S-layer protein contains two mature SLPs derived 
from a common precursor. The high molecular weight SLP (about 47 kDa) acts as a binding 
subunit, and the low molecular weight SLP (about 36 kDa) modulates colonization and 
pathogenesis (Takeoka et al., 1991; Calabi et al., 2001). The role of the C. difficile S-layer in 
colonization, immunity, virulence and viability has been well-studied (Calabi et al., 2002; 
Pechine et al., 2005; Ausiello et al., 2006; Pechine et al., 2007; Kirk et al., 2017). Several other 
CWPs such as Cwp84, Cwp2, Cwp66, and CwpV, have been investigated, and play important 
roles in host cell adhesion and immune system evasion during CDI (Waligora et al., 2001; 
Emerson et al., 2009; Kirby et al., 2009; Bradshaw et al., 2017; Wydau-Dematteis et al., 2018). 
Kirby et al. (Kirby et al., 2009) identified a surface-associated protease, Cwp84, which cleaves 
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SlpA precursor into mature form. Bradshaw et al. (Bradshaw et al., 2017) determined the 
structure of Cwp2 and demonstrated that cwp2 mutation resulted in increased TcdA release and 
impaired cellular adherence in vitro. Cwp66, which works as an adhesin, and CwpV, which 
confers phase-variable phage infection resistance, were also characterized (Waligora et al., 2001; 
Emerson et al., 2009; Sekulovic et al., 2015). Recently, a new surface protein Cwp19, which is a 
novel lytic transglycosylase involved in stationary-phase autolysis and can affect toxin release in 
C. difficile, was also identified (Wydau-Dematteis et al., 2018). Biazzo et al. (Biazzo et al., 2013) 
analyzed 14 of the other 17 CWP genes scattered throughout the C. difficile genome, and 
identified the conserved DNA sequences and protein expression of Cwp13, CwpV, Cwp16, 
Cwp18, Cwp19, Cwp20, Cwp22, Cwp24 and Cwp25, suggesting that these CWPs may possess 
important functions in C. difficile. However, the roles of some CWPs, such as Cwp22, Cwp24, 
and Cwp25, in vivo are still not very clear. 
The biochemical function of Cwp22 (CD630_27130) as a L, D-transpeptidase has been 
demonstrated in C. difficile 630 (Peltier et al., 2011; Sutterlin et al., 2018). Here, we identified 
the homologous protein (CDR20291_2601) from the epidemic strain C. difficile R20291 
(referred hereafter as R20291) using a reverse vaccinology method and studied the role of this 
protein in vivo by phenotypically characterizing a strain with an insertional inactivation of the 
cwp22 gene (CDR20291_2601, referred hereafter as 2601 gene). The cwp22 mutation results in 
decreased toxin production in the bacteria’s early growth, delayed sporulation, and decreased 
motility. Moreover, the cwp22 mutation impaired cellular adherence in vitro, decreased 
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cytotoxicity and fitness compared to the parent strain in a mouse infection model. Furthermore, 
cell viability assay through LDH cytotoxicity detection, live-dead cell staining and transmission 
electron microscope (TEM) analysis revealed that the cell autolysis and the cell wall 
permeability of the mutant were increased. Taken together, Cwp22 is an important cell wall 
protein involved in cell wall integrity and permeability, affecting most phenotypes of R20291, 
which could also be a new potential target for C. difficile vaccine development. 
Results 
Bioinformatic identification and analysis of putative cell wall protein Cwp22 
Vaxign is a web-based reverse vaccinology tool that uses comparative genomic sequence 
analysis to predict vaccine candidates based on different criteria such as cellular localization and 
adhesion probability (He et al., 2010). Using R20291 as the seed strain, Vaxign analysis 
predicted 31 C. difficile proteins to be cell membrane bound, likely to be adhesins, and conserved 
in other 12 genomes. Among these proteins is YP_003219080.1 (Cwp22), a putative cell wall 
protein of 653 amino acids with a predicted molecular weight of 71.97 kDa and a pI of 8.89. 
Cwp22 is encoded by the CDR20291_ 2601 (2601) gene in strain R20291 (NCBI Entrez Gene 
ID of 8468749).  
Based on conserved domain analysis, Cwp22 has a putative 37-amino acid signal sequence 
and three domains (Fig. 1A). The putative N-terminal catalytic domain belongs to the Erfk 
(YkuD) superfamily (COG1376) with L,D-transpeptidase activity, the C-terminal domain 
contains three tandem repeats of the cell wall binding motif CWB2 (pfam04122), and the 
6 
 
This article is protected by copyright. All rights reserved.
Glucan-binding domain belongs to the COG5263 superfamily, which plays role of carbohydrate 
transport and metabolism. The similar domains of Cwp22 (CD630_27130) in C. difficile 630 
were identified and characterized in vitro in previous work  (Peltier et al., 2011; Sutterlin et al., 
2018). 
Construction of cwp22 mutant and complementation strain 
To analyze the role of Cwp22, the ClosTron system was used to inactivate the 2601 gene. 
Insertion of the Group II intron into the 2601 gene was verified by intron and 2601gene specific 
primers 1-F/R and 2-F/R (Fig. 1B and C). The single chromosomal insertion of the intron was 
further confirmed by Southern blot analysis (Fig. 1D). Meanwhile, reverse transcription PCR 
(RT-PCR) and real time quantity PCR (RT-qPCR) were conducted using primers 2-F/R, 3-F/R, 
4-F/R and Co-F/R to confirm truncation of cwp22 and no polar effect of cwp22 mutation on up / 
down stream genes (Fig. 1E and F).  
Effects of cwp22 mutation on growth profile and toxin expression 
The effect of the cwp22 mutation on R20291 growth was first analyzed in BHIS medium. Fig. 
S1A showed that R20291::2601 reached higher cell density (OD600) at the stationary phase. 
However, when the mutant entered into the late stationary phase, the turbidity of the mutant 
cultures (16 - 36 h) decreased faster than R20291 indicating that the mutant autolyzed faster than 
the parent (Fig. S1B and C). 
To assay the effect of the cwp22 mutation on toxin production, the toxin concentration of 
culture supernatants collected at 12, 24, 36 and 48 h of post inoculation were determined by 
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ELISA. Our preliminary data showed that there is no significant difference in toxin expression of 
R20291 VS R20291/pMTL84153 and R20291::2601 VS R20291::2601/pMTL84153 (data not 
shown). Therefore, we just compared R20291, R20291::2601 and R20291::2601/pMTL84153-
2601. Fig. 2A showed that the TcdA concentration of R20291::2601 supernatants was 
significantly lower than that of R20291 before 36 h (at 12 h: 3.1-fold less, 24 h: 2.9-fold less, 36 
h: 0.7-fold less), and reached a similar level at 48 h compared to R20291. Interestingly, the TcdB 
concentration of R20291::2601 was 1.5-fold of that of R20291 at 12 h with significant difference, 
and reached a similar level after 12 h. 
To analyze the expression of the tcdA and tcdB genes, RT-qPCR was performed. As shown 
in Fig. 2B, tcdA (tcdB) transcription in R20291 was about 5.2 (2.8) fold (*P ˂ 0.05) at 12 h, 1.5 
(1.9) fold (*P ˂ 0.05) at 24 h, 1.1 (1.3) fold at 36 h and 0.87 (1.1) fold at 48 h of those in 
R20291::2601. The transcription level of the tcdA gene was consistent with the ELISA results of 
the supernatants. Surprisingly, the transcription of the tcdB gene was not consistent with the 
ELISA results. To further check the production of TcdA and TcdB, the intracellular TcdA and 
TcdB were measured by Western blot analysis (Fig. 2C). We tried to use anti-E. coli RNA 
polymerase β antibody (no available antibody for Gram - positive bacteria) to detect the RNA 
polymerase β subunit of C. difficile which could be used as a control protein for Western blot 
analysis, but the antibody did not work in C. difficile. Therefore, we detected the total lactate 
dehydrogenase (LDH) concentration (supernatants and intracellular fluids) of C. difficile by 
ELISA, and used it as the calibration protein for Western blot histogram analysis. Fig. 2C 
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showed that the intracellular TcdA / TcdB production of the mutant was lower than the parent, 
which was consistent with the transcriptional analysis results. These results indicated that the cell 
wall permeability and composition of the cwp22 mutant might be altered, which could affect 
toxin release. 
Total toxin production was further evaluated by measuring cytotoxic titer of C. difficile 
culture supernatants. To assay toxin titer, CT26 cells were exposed to 24, 36 and 48 h of post 
incubated C. difficile supernatants, respectively. Fig. 3 showed that the relative cytotoxic titer of 
R20291 supernatants was 2.0 fold that of R20291::2601 supernatants at 24 h (*P ˂ 0.05), 1.4 
fold at 36 h (*P ˂ 0.05) and reached a similar cytotoxicity level at 48 h. Results indicated that the 
cytotoxicity of the cwp22 mutant decreased compared to the wild type before 36 h, and reached 
the same level at 48 h. 
Effects of cwp 22 mutation on cell wall integrity 
 In order to determine if the cwp22 mutation affects C. difficile autolysis, a Triton X-100 
autolysis assay was conducted. As shown in Fig. 4A, R20291::2601 lysed significantly faster 
than R20291 at 80 and 120 min of incubation (*P ˂ 0.05), suggesting that mutation of cwp22 
decreased bacteria resistance to Triton X-100, and increased autolysis of R20291.  
To check whether the cell wall of R20291::2601 was altered, we detected the LDH 
cytotoxicity of C. difficile strains. Fig. 4B showed the permeability of R20291::2601 was higher 
than R20291 with a significant difference after 12 h of incubation (*P ˂ 0.05), suggesting that 
the cell wall permeability of the cwp22 mutant might be changed. 
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To further analyze the effect of the cwp22 mutation on the cell, we analyzed C. difficile 
cell viability through live-dead cell staining and TEM. Four areas of cells (>400 cells) on slide 
were counted with microscope software (Dead bacteria were dyed as red color with PI, and live 
bacteria were dyed as green color with CDFA), and the percent of ghost cells accounted in total 
cells was calculated (Fig. 4C). As shown in Fig. 4C and 4D, significantly more empty cells of 
R20291::2601 were found before 36 h incubation (*P ˂ 0.05), indicating more cell wall 
permeability and cell autolysis of the mutant compared to R20291.  
cwp22 mutation reduces bacterial adhesion in vitro 
The ability of vegetative cells and spores to adhere to HCT-8 cells in vitro was assayed. Fig. 5 
showed that for vegetative cells, the mean adhesion of R20291 was 1.73 ± 0.30 bacteria / cell, 
while R20291::2601 was 0.19 ± 0.01, which decreased by 89% (**P ˂ 0.01), the 
complementation strain was 1.8 ± 0.31; for spores, the mean adhesion of R20291 was 3.17 ± 
0.30, while R20291::2601 was 0.28 ± 0.02, which decreased by 91% (**P ˂ 0.01), the 
complemented strain was 4.47 ± 0.94 (*P ˂ 0.05). These data suggested that the adherence of the 
cwp22 mutant was significantly lower than the parent in both vegetative cells and spores.  
Effects of cwp22 mutation on biofilm formation, motility and spore resistance to heat / 
ethanol 
To further characterize the effect of cwp22 mutation on C. difficile physiology, the ability of C. 
difficile strains to form biofilms, motility and spore resistance to heat / ethanol were analyzed. 
Fig. S2 showed the biofilm of R20291::2601 decreased 45% (**P ˂ 0.01) at 24 h and 15% (*P ˂ 
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0.05) at 72 h compared to R20291. To assay the motility, swarming and swimming abilities of C. 
difficile strains were determined at 48 h and 24 h incubation, respectively. Fig. S3 showed the 
diameter of the swarming zone of R20291::2601 (15.15 ± 1.2 mm), decreased by 23% (*p < 0.05) 
compared to R20291 (19.70 ± 1.6 mm). Meanwhile, the diameter of the swimming zone of the 
mutant (13.94 ± 2.1 mm,) decreased by 38% (*p < 0.05) compared to R20291 (22.33 ± 2.9 mm). 
The sucrose gradient purified C. difficile spores (Racine and Vary, 1980) were used to detect the 
resistance to heat (65 ℃) and ethanol (100% ). Fig. S4 showed that there was no significant 
difference in spore resistance between R20291::2601 and R20291. 
Effects of cwp22 mutation on sporulation and germination  
Sporulation and germination of C. difficile strains were analyzed. R20291::2601 (5.23% ± 2.21% 
at 24 h, *p < 0.05; 36.67% ± 4.37% at 48 h, *p < 0.05) showed significantly delayed sporulation 
compared with R20291 (21.33% ± 2.41% at 24 h; 87.23% ± 3.12%) at 24 h (Fig. S5A), while at 
72 h, the sporulation ratio of the mutant was almost the same as the parent. As shown in Fig.S5B 
and 5C, there is no significant difference in germination ratio between R20291::2601 and 
R20291. 
Evaluation of cwp22 mutation on C. difficile virulence and adhesion in mouse model of C. 
difficile infection 
To evaluate whether cwp22 mutation affects bacterial virulence and adhesion in vivo, a mouse 
model of CDI was performed. Thirty mice (n=10 per group) were challenged with R20291, 
R20291::2601 or R20291::2601/pMT84153-2601 spores (1 × 106 spores / mouse) via gavage 
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after antibiotic treatment. The R20291::2601 infection group lost less weight compared to the 
R20291 infection group, and there was a significant difference at day post challenge 1 (Fig 6A). 
Fig. 6B showed that 40% of mice succumbed to severe disease within 3 days in the R20291 
infection group compared 10% mortality in the group infected with R20291::2601 (no significant 
difference with log-rank analysis). Meanwhile, 90% of mice developed diarrhea in the R20291 
infection group versus 70% in the mutant infection group (Fig. 6C). As shown in Fig. 6, the CFU 
of the R20291::2601 infection group decreased both in fecal samples (Fig. 6D) and cecum (Fig. 
6E) compared to the R20291 infection group, and there was a significant difference in fecal 
samples at days post challenge 1, 2 ,4 and 5, while no significant difference in adherence to the 
cecum was detected. To analyze the persistence ratio of the complementation plasmid in 
R20291::2601, the number of R20291::2601/pMT84153-2601 in fecal samples were counted 
(Table S2). The results showed that the 2601 gene was helpful to maintain pMTL84153-2601 in 
R20291::2601 and there was no significant difference in plasmid persistence at days post 
challenge 1 compared to the original charged spores (100%). While the complementation 
plasmid pMTL84153-2601 in R20291::2601 was not very stable after days post challenge 2 
without antibiotic selection, the complementation still can be reached to a certain extent. 
To analyze toxin level in the gut, the titer of TcdA and TcdB in feces was measured (Fig. 
6F). A comparison between the cwp22 mutant and the wild type strain revealed significant toxin 
decrease in mutant feces at days post challenge 1 (TcdA: 27% less, *p < 0.05; TcdB: 30% less, 
*p < 0.05), 2 (TcdA: 29% less, *p < 0.05; TcdB: 31% less, *p < 0.05) and 4 (TcdA: 18% less, *p 
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< 0.05). The above results indicated that the cwp22 mutation impaired the colonization and 
pathogenesis ability of R20291. 
Discussion 
In this study, we reported the identification and characterization of a putative surface protein 
Cwp22 from C. difficile R20291. Our data showed that Cwp22 was involved in several cellular 
processes of C. difficile such as toxin production, sporulation, bacteria motility and cell viability. 
Notably, the cwp22 inactivation increased cell permeability and autolysis, impaired cellular 
adherence in vitro, and decreased cytotoxicity with significant differences, and decreased 
virulence over the wild strain in the mouse infection model. Our results indicated that Cwp22 
could be a new potential target for CDI therapeutics and prophylactics. 
 The major virulence factors of C. difficile are two exotoxins, toxin A (TcdA) and toxin B 
(TcdB) (Voth and Ballard, 2005). The toxin encoding genes tcdA and tcdB are located in a 19.6 
kb pathogenicity locus (PaLoc), which also contains three additional genes, tcdC, tcdR and tcdE 
(Braun et al., 1996; Mani and Dupuy, 2001). TcdC is an antagonist of TcdR that negatively 
regulates TcdR-containing RNA polymerase holoenzyme (Dupuy et al., 2008). While previous 
studies showed that TcdC might have a moderate role in regulating toxin expression, it is not a 
major determinant of the hypervirulence of C. difficile (Murray et al., 2009; Bakker et al., 2012; 
Martin-Verstraete et al., 2016). tcdR has been shown to encode an RNA polymerase sigma factor 
that positively regulates both toxin genes and its own gene (Moncrief et al., 1997; Mani et al., 
2002). In this study, our data suggested that both TcdA and TcdB expression were decreased 
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before 24 h of post inoculation, these results prompted us to examine the tcdR transcription. The 
transcription analysis of tcdR showed that the transcription of tcdR in R20291::2601 decreased 
2.3 folds (*p<0.05) at 12 h, 1.2 folds (*p<0.05) at 24 h and 0.5 fold at 36 h (*p< 0.05) compared 
to the wild strain, and reached a similar expression level after 48 h of post inoculation (Fig. S6A). 
TcdR acts a positive regulator of toxin expression, and is regulated by many other network 
regulators, such as CcpA, CodY and σD (El Meouche et al., 2013; Martin-Verstraete et al., 2016). 
El Meouche et al. (El Meouche et al., 2013)) demonstrated that SigD could positively regulate 
toxin expression via direct control of tcdR. In our study, the sigD expression of the cwp22 mutant 
decreased 6.2 folds (**p < 0.01) at 12 h and 0.8 fold (*p < 0.05) at 24 h compared to the wild 
type strain, and reached a similar expression level after 36 h of post inoculation (Fig. S6B). In El 
Meouche’s study, they also confirmed that SigD is implicated in the positive regulation of C. 
difficile motility as reported previously (Aubry et al., 2012). We also demonstrated that both the 
swarming (decreased by 23%, *p < 0.05) and swimming (decreased by 38%, *p < 0.05) abilities 
of the cwp22 mutant decreased compared to the wild strain (Fig. S3). As Fig. S7 showed, the 
motility related gene fliC of mutant was expressed 2-fold less (*p < 0.05) than the wild type 
strain at 24 h through RT-qPCR analysis. Toxin release is the key factor in pathogenesis, while 
the mechanism of toxin transportation is still unclear. TcdE, the holin-like protein coded by tcdE, 
has been identified as being involved in toxin release (Govind and Dupuy, 2012; Olling et al., 
2012; Govind et al., 2015). But, the results of the TcdE studies from different groups were 
controversial. On the one hand, the function of TcdE in toxin release in C. difficile JIR8094 and 
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R20291 cultured in tryptone-yeast (TY) broth was confirmed (Govind and Dupuy, 2012; Govind 
et al., 2015). On the other hand, Olling et al. (Olling et al., 2012) identified that the release of 
toxin from C. dificile 630∆erm is not affected by inactivation of the tcdE gene. Recently, it was 
identified that Cwp19 acts as a novel lytic tansglycosylase, which is involved in toxin release 
through stationary-phase autolysis in C. difficile 630∆erm (Wydau-Dematteis et al., 2018). In 
that study, Wydau-Dematteis et al. (Wydau-Dematteis et al., 2018) proved that TcdE and 
bacteriolysis were coexisting mechanisms for toxin release, with their relative contributions in 
vitro depending on growth conditions (works in BHIS not in TY). In this study, we also detected 
the increase of autolysis and cell permeability of the cwp22 mutant compared to the parent strain. 
Taken together, we propose that the decreased expression of the sigD gene contributed to the low 
expression of toxin and motility of R20291::2601 though the cell permeability was increased. As 
the regulation of toxin production is a complex response of C. difficile to particular nutrient 
availability, the transcriptome analysis of R20291::2601 would provide us new knowledge on the 
regulation map of the cwp22 mutation on toxin production as well as some other pleiotropic 
phenotype changes, such as sporulation and germination. 
Cwp22, a putative cell wall protein, is composed of a β-sandwich and a conserved active 
site consisting of a (Y/L)XXHG(S/T) motif followed by SXGC(I/V)R(M/L) (Bradshaw et al., 
2018). It contains an ErfK (YkuD) domain followed by 8 type 1 cell wall binding (CWB1- 
Clucon binding domain) repeats and 3 type 2 cell wall binding domains (CWB2) which mediate 
the adherence of Cwp22 to the cell wall through interaction with the anionic polymer PSII 
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(Willing et al., 2015; Bradshaw et al., 2018). While L,D-transpeptidase enzyme activity of 
Cwp22 in R20291 was predicated through bioinformatics analysis with NCBI’s Conserved 
Domain Database (CDD), the Cwp22 protein from R20291 was successfully expressed and 
purified (data not shown), and the enzyme activity analysis is under way in our group. The ErfK 
domain is found in L,D-transpeptidase (Cwp22), which are involved in peptidoglycan 
crosslinking like D,D-tanspeptidase. Previous studies showed that the peptidoglycan of C. 
difficile contains an unusually high (73%) content of 3→3 cross-links generated by L,D-
transpeptidases compared to all other firmicutes, and the L,D-transpeptidases could confer 
resistance to β-lactam antibiotics (Biarrotte-Sorin et al., 2006; Peltier et al., 2011). Interestingly, 
we didn’t detect a significant MIC difference for β-lactam antibiotics between the cwp22 
mutant and R20291 (data not shown), which indicates that some other enzyme could also play 
the same role of L,D-transpeptidase in R20291. Recently, Peltier et al. (Peltier et al., 2011) and 
Sutterlin et al. (Sutterlin et al., 2018) identified and purified three L,D-transpeptidases, 
CD630_29630 (LdtCd1), CD630_27130 (LdtCd2), and CD630_30070 (LdtCd3), in C. difficile 630. 
Among them LdtCd2 and LdtCd3 can catalyze the formation of 3→3 cross-links (L,D-
transpeptidase activity), while LdtCd1 displays only L,D-carboxypeptidase activity (Sutterlin et al., 
2018). They demonstrated that the inactivation of the ldtCd1, ldtCd2, and ldtCd1 plus ldtCd2 could 
result in a 22%, 15%, and 28% decrease in the proportion of muropeptide dimers containing 
3→3 cross-links, respectively. Meanwhile, they also found that the proportion of 4→3 cross-
links was reduced by 4%, 4%, and 3% compared to the wild type strain with unknown reasons in 
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the ldtCd1, ldtCd2, and ldtCd1 plus ldtCd2 mutation strains, respectively. These observations showed 
that each of the ldtCd1, ldtCd2, or ldtCd1 could result in significant decrease in the abundance of 
3→3 cross-links and in overall peptidoglycan reticulation, which could reconstruct the bacterial 
cell wall constitution (Peltier et al., 2011; Sutterlin et al., 2018). Based on the protein sequences 
of L,D-transpeptidases found in C. difficile 630, we also searched three homologous proteins 
which were predicated as L,D-transpeptidases in R20291, they are CDR20291_2797 (99.36% 
identity to LdtCd1), CDR20291_2601 (Cwp22, 99.22% identity to LdtCd2), CDR20291_2843 
(98.59% identity to LdtCd3). Though Cwp22, as LdtCd2, has been identified in previous studies 
which could change cell wall composition, the pleiotropic roles of Cwp22 in C. difficile were not 
demonstrated till now. In this present study, our results showed that the cwp22 mutation could 
result in increased cell autolysis, decreased cell viability and adherence to HCT-8 cells in vitro 
and the mouse gut in vivo and decreased pathogenesis in mice, which confirmed that the cell 
wall protein Cwp22 (LdtCd2) mutation could indirectly reconstruct the cell wall. We also tried 
to extract the cell wall protein with low PH method (Calabi et al., 2001) to check the 
constitution change of the R20291::2601 cell wall compared to R20291, but we didn’t get a 
clear significant difference result by running a normal SDS-PAGE gel (data not shown). The 
cell wall proteomics analysis combined with LC-MS analysis could be used to highlight the 
subtle changes of the R20291::2601 cell wall in future studies. 
Over the past decade, CDI has become a serious problem in the developed world, and 
results in an estimated 29,000 deaths and an estimated cost of $1-3 billion in the United States 
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alone (Dubberke and Olsen, 2012; Lessa et al., 2015; Zhu et al., 2018). However, many aspects 
of CDI remain unclear, in particular the mechanisms of C. difficile colonization in the gut. 
Although CWPs involved in bacteria colonization have been identified, more CWPs need to be 
studied for their important roles in CDI and potential application in developing new therapeutics 
and prophylactics in C. difficile. Like other bacteria, C. difficile also possess multiple adhesins, 
and several CWPs have been previously characterized, including SlpA, Cwp2, Cwp6, CwpV, 
Cwp66, Cwp84 and Cwp19 (Waligora et al., 2001; Wright et al., 2005; Kirby et al., 2009; Dang 
et al., 2010; Reynolds et al., 2011; Bradshaw et al., 2017; Ferreira et al., 2017; Wydau-Dematteis 
et al., 2018). Although the exact role of each CWP in pathogenesis remains to be further 
elucidated, antibodies to many CWPs have been found in serum samples from CDI patients, and 
investigational vaccines targeting Cwp84 (Pechine et al., 2011; Sandolo et al., 2011) have been 
developed, indicating that certain CWPs are surface exposed in vivo and could be developed into 
vaccines (Pechine et al., 2005; Wright et al., 2008; Biazzo et al., 2013). Cell wall proteins and 
adhesins are favorable protective antigens for vaccine development against infection with Gram-
positive bacterial pathogens (He et al., 2014; Ong et al., 2017). A recent study of manually 
annotated protective vaccine antigens from over 10 Gram-positive bacteria found 56.8% of these 
protective antigens are adhesins or adhesin-like proteins. In addition, 19.8% of the protective 
antigens in Gram-positive bacteria were found to be located in the cell wall, and 87.5% of these 
protective cell wall antigens are also adhesins (Ong et al., 2017). Cwp22, like the other cell wall 
proteins Cwp2, Cwp6, CwpV, Cwp22, Cwp19 and Cwp84, is also an abundant and conserved 
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protein in C. difficile through gel free analysis of the extracts (Ferreira et al., 2017), suggesting 
that it is required for some cellular processes. Meanwhile, Cwp22 (CDR20291_2601 gene) ranks 
top of candidates including cwp84 and slpA, which was predicated by Vaxign tool for exploring 
novel potential surface proteins with potential adhesion activity. Therefore, as a cell wall protein, 
Cwp22 is a very promising protective vaccine antigen. An immune response against Cwp22 
would block its pleiotropic functions and lead to possible effective protection against C. difficle 
infection.  
In conclusion, we characterized the surface protein Cwp22 in R20291, and detected the 
pleiotropic functions of Cwp22. Cwp22 is an attractive target for vaccine development, and the 
evaluation of the capacity of Cwp22 to induce a protective immune response is under way in our 
group. 
Experimental Procedures 
Comparative genomic analysis of C. difficile genomes  
Using the Vaxign reverse vaccinology tool (He et al., 2010), we systematically analyzed all 
proteins in the genome of C. difficile R20291 in terms of cellular localization, adhesin 
probability, transmembrane helices, sequence conversation with the genomes of other 12 C. 
difficile strains, sequence similarity to human and mouse proteins, and protein length. These 
other 12 strains are strains 630, BI1, ATCC 43255, CD196, CIP 107932, QCD-23m63, QCD-
32g58, QCD-37x79, QCD-63q42, QCD-66c26, QCD-76w55, and QCD-97b34. Protein 
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conserved domain analysis was performed using the NCBI's Conserved Domain Database (CDD) 
(Marchler-Bauer et al., 2017). 
Bacterial strains, plasmids and culture conditions  
Table 1 lists the strains and plasmids used in this study. C. difficile strains were cultured in BHIS 
(brain heart infusion broth supplemented with 0.5% yeast extract and 0.1% cysteine) at 37 ℃ in 
an anaerobic chamber (90% N2, 5% H2, 5% CO2). For production of spores, C. difficile strains 
were cultured in Clospore medium as described (Perez et al., 2011). Escherichia coli DH5α and 
E. coli HB101 were grown aerobically at 37 ℃ in LB media (1% tryptone, 0.5% yeast extract, 1% 
NaCl). Antibiotic selection was used when needed: for E. coli (per milliliter), 15 μg of 
chloramphenicol; for C. difficile (per milliliter), 15 μg thiamphenicol, 50 μg kanamycin, 250 μg 
D-cycloserine, 8 μg cefoxitin, and 20 μg lincomycin. 
DNA manipulations and chemicals 
DNA manipulations were carried out according to standard techniques (Chong, 2001). 
Recombinant plasmids were conjugated into C. difficile according to the method described 
earlier (Heap et al., 2010). The DNA markers, T4 DNA ligase, restriction enzymes, PCR product 
purification kit, DNA gel extraction kit, First-strand cDNA synthesis kit, and SYBR Green RT-
qPCR kit were purchased from Thermo Fisher Scientific (Waltham, USA). Plasmid DNA, 
chromosomal DNA, and total RNA were isolated using QIAGEN column (Qiagen, UK). PCRs 
were performed with the high fidelity DNA polymerase NEB Q5 (New England, UK). Primers 
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(Table S1) were synthesized by IDT (Coralville, USA). All chemicals were purchased from 
Sigma (St. louis, USA) unless those stated otherwise. 
Construction of cwp22 mutant and complementation strains 
The ClosTron system was used for inactivation of the 2601 gene (cwp22) as described previously 
(Heap et al., 2010). The 353 bp retarget intron was designed on the website 
(http://clostron.com/clostron2.php?), and was synthesized and cloned into the plasmid 
pMTL007C-E2, producing pMTL007C-E2-2601, with services of ATUM company 
(https://www.atum.bio/eCommerce/login), and subsequently was conjugated into R20291. 
Successful transconjugants were selected with selective plate BHIS-TKC (15 μg/ml 
thiamphenicol, 50 μg/ml kanamycin, 8 μg/ml cefoxitin). Subsequent correct intergrants 
(R20291::2601) were selected on BHIS-Lm (20 μg/ml lincomycin) plates.  
The 2601 gene, a 1962 bp fragment, was amplified with primers Re-F/R. The PCR 
products flanked with SacI-BamHI restriction enzyme sites were digested, and then cloned into 
pMTL84153 plasmid which was constructed from pMTL84151 and pMTL82153, yielding the 
complemented plasmid pMTL84153-2601, and subsequently was conjugated into R20291::2601 
and verified by PCR, yielding the complemented strain R20291::2601/pMTL84153-2601. The 
empty plasmid pMTL84153 was also conjugated into R20291 and R20291::2601 as negative 
controls, respectively. 
Confirmation of the cwp22 mutation by PCR and Southern hybridization 
21 
 
This article is protected by copyright. All rights reserved.
PCR was performed to confirm the insertion of the targetron in the right position with primers 1-
F/R and 2-F/R. Meanwhile, RT-PCR and RT-qPCR were conducted using primers 2-F/R, 3-F/R 
and 4-F/R to confirm truncation of cwp22 mRNA and no polar effect of cwp22 mutation on up / 
down stream of genes, respectively. All RT-qPCRs were repeated in triplicate, independently. 
Data analysis was conducted by using the comparative CT (2-∆∆CT) method with16s rRNA as 
control. Primers Co-F/R were used to verify the co-transcription of 2602 and 2601 genes. 
Southern blotting was used to identify the single copy insertion of the targetron in the genome 
(Waligora et al., 2001). For Southern hybridization, the genome (5 μg) of R20291 and 
R20291::2601 were digested with either EcoRI-HindIII or EcoRI-XbaI. The specific probe was 
synthesized using the intron/ermB sequence as a template with the DIG High Prime DNA 
Labelling and Detection Starter kit I (Sigma, St. louis, USA), generated using the oligonucleotide 
primer Perm. 
Growth profile, toxin expression and cytotoxicity assay 
C. difficile strains were cultured to an optical density of OD600 of 0.8 in BHIS, and then diluted 
to an OD600 of 0.2. One milliliter of culture dilution was inoculated into 100 ml BHIS, followed 
by measuring OD600 for 48 h. 
For determination of toxin concentration in C. difficile cultures, 10 ml of C. difficile 
cultures were collected at 12, 24, 36 and 48 h post inoculation. The OD600 of cultures were 
adjusted to the same value with fresh BHIS. Then the cultures were centrifuged at 4 ℃, 12000×g 
for 5 min, filtered with 0.22 μm filter and used for ELISA. For the intracellular toxin analysis, 
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the centrifuged C. difficile pellets were washed 3 times with PBS, and resuspended in 2 ml of 
PBS with 200 μl of 0.2 mm glass beads. Afterwards, the bacteria were vortexed at 4 ℃ for 20 
min, following centrifuged at 4 ℃, 12000×g for 5 min. Th     the bacteria 
lysis were normalized to the same protein concentration with BCA (bicinchoninic acid) protein 
assay, and used for intracellular toxin detection by Western blot analysis and ELISA. Anti-TcdA 
(PCG4.1, Novus Biologicals, USA) and anti-TcdB (AI, Gene Tex, USA) were used as coating 
antibodies for ELISA, HRP-Chicken anti-TcdA and HRP-Chicken anti-TcdB (Gallus 
Immunotech, USA) were used as detection antibodies in both ELISA and Western blot analysis. 
For toxin transcription analysis, cultures of C. difficile strains were collected at 12, 24, 36 
and 48 h of post inoculated, respectively. Then the total RNA was extracted with TRIzol reagent. 
The transcription of tcdA and tcdB was determined through RT-qPCR with primers tcdA-F/R and 
tcdB-F/R, respectively. All RT-qPCRs were repeated in triplicate, independently. Data analysis 
was conducted by using the comparative CT (2-∆∆CT) method with16s rRNA as a control. 
To determine cytotoxicity of C. difficile cultures, cytotoxic titers of culture supernatants 
were determined according to the revised protocol (Winston et al., 2016). Briefly, 1 ml of a 24, 
36 and 48 h BHIS cultured strains were collected and adjusted to the same OD600. Then the 
cultures were centrifuged at 4 ℃, 12000×g for 10 min, and filtered with 0.22 µm filters. 
Afterwards, the supernatants were serially diluted by 2-fold with PBS, and 50 µl of supernatants 
were added into 50 µl of CT-26 cells with 95% confluence (105/well) in a 96-well plate, 
followed incubating overnight at 37 °C / 5% CO2. Cell morphology alterations were monitored 
23 
 
This article is protected by copyright. All rights reserved.
and imaged under a microscope after overnight incubation. The cytotoxic titer was defined as the 
reciprocal of the highest dilution that caused 50% CT26 cell rounding (Winston et al., 2016). 
CT26 cells treated with purified Tcd B and BHIS media were used as positive and negative 
controls, respectively.  
Cell autolysis, LDH cytotoxicity and cell viability analysis 
To determine Triton X-100 induced-autolysis, C. difficile strains were cultured to an OD600 of 
0.8 to log phase, then 5 ml of each culture was collected and washed with 50 mM potassium 
phosphate buffer (pH 7.0). The pellets were resuspended in a final volume of 2.5 ml of 50 mM 
potassium phosphate buffer containing 0.01% of Triton X-100. Afterwards, the bacteria were 
incubated anaerobically at 37 °C, and the OD600 was detected at 0, 0.5, 1, 2, 4, and 6 h. The lysis 
percent was shown as % initial OD600. 
For the LDH cytotoxicity analysis, the supernatants from different strains were collected, 
and filtered with 0.22 μm filters as described above, then the LDH concentration of the 
supernatants was detected with the PierceTM LDH Cytotoxicity Assay Kit (Thermo Fisher, USA) 
according to the instructions of the manufacturer. 
For cell viability analysis, the live-dead cell staining was performed (Fuller et al., 2000; 
Stiefel et al., 2015). Briefly, 12, 24, 36 and 48 h post incubated C. difficile strains were collected 
and cell number was normalized to 108 CFU/ml, respectively. Then 1 ml of each strain cultures 
was centrifuged at 4 ℃, 5000×g for 10 min, and washed with PBS for 3 times. Afterwards, the 
bacteria were resuspended in 100 μl of 0.1 mM sodium phosphonate buffer. The chemical 5(6)-
24 
 
This article is protected by copyright. All rights reserved.
CFDA (5-(and -6)-Carboxyfluorescein diacetate) was used to dye live C. difficile, and the 
propidium iodide (PI) was used to dye dead bacteria. The final concentration of 50 mM 5(6)-
CFDA and 200 ng/ml of PI were used to co-dye C. difficile strains, following addition of the dye 
mixture, C. difficile cells were incubated at 4 ℃ overnight for monitoring  Flu rescence
Microscope. The CFDA and PI were excited at 495 nm and 538 nm, respectively. To further 
detect the cell viability change of C. difficile strains, transmission electron microscope (TEM) 
analysis was performed. Specimens were prepared according to the previous method used in C. 
difficile (Baban et al., 2013; Calderon-Romero et al., 2018), and detected by JEM-1400 (Jeol Ltd., 
Tokyo, Japan) TEM. Briefly, 1 ml of bacterial cultures were collected and fixed with 2.5% 
gluteraldehyde (GA). After fixation, samples were post-fixed with 1% osmium tetroxide (EMS) 
and dehydrated with a graded series of ethanol (30, 50, and 70), followed resuspended in 70% 
ethanol for TEM detection directly.  
Adhesion of C. difficile vegetative cells and spores to HCT-8 cells 
The adhesion ability of vegetative cells and spores was evaluated with HCT-8 cells (ATCC 
CCL-244) (Janvilisri et al., 2010). Briefly, cells were grown to 95% confluence (2×105/well) in a 
24-well plate, followed by infection with 6 × 106 of vegetative cells (log phase) or spores at a 
multiplicity of infection of 30:1, and cultured in the anaerobic chamber at 37 ℃ for 1 h. After 
incubation, the infected cells were washed and suspended in RPMI media, and plated on BHIS 
plates with 0.1% TA to enumerate the adhered vegetative cells or spores. The ability of C. 
25 
 
This article is protected by copyright. All rights reserved.
difficile strains to adhere to HCT-8 cells was calculated as follows: CFU adhered vegetative cells 
or spores / Total cell numbers. 
Evaluation of virulence of R20291 and cwp22 mutant in the mouse model of C. difficile 
infection 
C57BL/6 female mice (6 weeks old) were purchased from Charles River Laboratories, MA. All 
studies were approved by the Institutional Animal Care and Use Committee of University of 
South Florida. The experimental design and antibiotic administration were performed as 
previously described (Sun et al., 2011). Briefly, 30 mice were divided into 3 groups in 6 cages. 
Group 1 was challenged with R20291 spores, group 2 with R20291::2601 spores, and group 3 
with R20291::2601/pMTL84153-2601 spores, respectively. Mice were given an orally 
administered antibiotic cocktail (kanamycin 0.4 mg/ml, gentamicin 0.035 mg/ml, colistin 0.042 
mg/ml, metronidazole 0.215 mg/ml, and vancomycin 0.045 mg/ml) in drinking water for 4 days. 
After 4 days of antibiotic treatment, all mice were given autoclaved water for 2 days, followed 
by one dose of clindamycin (10 mg/kg, intraperitoneal route) 24 h before spores challenge (Day 
0). Afterwards, mice were orally challenged with 106 of spores by gavage, and monitored daily 
for a week for changes in weight, diarrhea, mortality and other symptoms of the disease.  
Enumeration of C. difficile in feces and cecum tissues, and determination of toxin levels in 
feces 
Fecal pellets were collected from post infection day 0 to day 7, and stored in -70 ℃.  To 
enumerate C. difficile numbers, feces were diluted into PBS at a final concentration of 0.1 g/ml. 
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Then 100 µl of the fecal solution was added to 900 µl of absolute ethanol, and kept at room 
temperature for 1 h to inactivate vegetative cells.  After that, fecal samples were serially diluted 
and plated on BHIS-CCT (250 μg/ml D-cycloserine, 8 μg/ml cefoxitin, 0.1% TA). The plates 
were incubated at 37 ℃ in the anaerobic chamber for 24 - 48 h, then the colonies were counted 
and expressed as CFU/g feces. To determine toxin tilter in fecal samples, 0.1 g/ml of fecal 
samples were diluted 2 times with PBS, then the concentration of TcdA and TcdB was measured 
by ELISA. To determine C. difficile adherence to the cecum, the intact cecum of the mice was 
collected on day 7, then weighted and homogenized in PBS at a final concentration of 10 mg/ml 
(Baban et al., 2013). Then, cecum samples were serially diluted and plated on BHIS-CCT plates, 
and the colonies were counted and expressed as CFU/g cecum. 
Statistical analysis 
The reported experiments were carried out in independent biological triplicates except animal 
experiments, and each sample was additionally taken in technical triplicates. Animal survivals 
were analyzed by Kaplan-Meier survival analysis. Student’s unpaired t-test was used for two 
groups comparison. One-way analysis of variance (ANOVA) was used for more than two groups 
comparison. Results are expressed as mean ± standard error of the mean. Differences were 
considered statistically significant if P < 0.05 (*).  
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Figure legends 
Fig. 1 Construction and identification of cwp22 mutant. 
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(A) Schematic representation of Cwp22 structure. Cwp22 contains a 37 amino acid signal 
peptide, and three main domains which are N-terminal catalytic domain, C-terminal three repeats 
cell wall binding motif CWB2 (pfam04122) and 8 type 1 cell wall binding (CWB1- glucan 
binding domain) repeats. (B) Up and down stream genes of 2601 (cwp22). P indicates promoter. 
(C) Identification of cwp22 mutation. M:1 kb DNA ladder; 1: ermB gene verification with 
R20291 genome using primer 1-F/R; 2: ermB gene verification with R20291::2601 genome 
using primer 1-F/R; 3: correct insertion verification with R20291 genome using primer 2-F/R; 4: 
correct insertion verification with R20291::2601 genome using primer 2-F/R. (D) Verification of 
single insertion mutation by Southern blot analysis. 1: ermB gene used as a positive control; 2: 
R20291::2601 genome digested with EcoRI and XbaI; 3: R20291::2601 genome digested with 
EcoRI and Hind III; 4: R20291 genome digested with EcoRI and Hind III used as a negative 
control.  (E) Verification of 2601 truncation and co-transcription of 2601 and 2602 genes. 1: Test 
of genomic contamination in total R20291 RNA using 16s primers; 2: Test of 2601 and 2602 co-
transcription with R20291 cDNA as template using primer Co-F/R; 3: Test of 2601 gene 
transcription with R20291::2601 cDNA as template using primer 2-F/R; 4: Test of 2601 gene 
transcription with R20291 cDNA as template using primer 2-F/R. (F) Test of polar effect of 2601 
gene inactivation on up and down stream genes.  Primers 2-F/R, 3-F/R and 4-F/R were used to 
detect the transcription of 2601, 2602 and 2600 genes, respectively. Experiments were 
independently repeated thrice. Bars stand for mean ± SEM. One-way analysis of variance 
(ANOVA) was used for statistical significance. 
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Fig. 2 Effect of cwp22 mutation on toxin expression.  
 (A) Determination of toxin concentration in C. difficile supernatants. (B) Determination of toxin 
expression on transcription level. (C) Determination of intracellular toxin concentration by 
western blot and histogram analysis. Experiments were independently repeated thrice. Bars stand 
for mean ± SEM, (*P<0.05, **P<0.01). One-way analysis of variance (ANOVA) was used for 
statistical significance. 
Fig. 3 Effect of cwp22 mutation on cytotoxicity of C. difficile supernatants on CT26 cells. 
The CT26 cells were exposed to 2-fold serial dilutions of C. difficile culture supernatants. The 
cytotoxic titer was defined as the reciprocal of the highest dilution that caused 50% CT26 cells 
rounding. Purified Tcd B and BHIS media were used as positive and negative controls, 
respectively. Experiments were independently repeated thrice. Bars stand for mean ± SEM, 
(*P<0.05). One-way analysis of variance (ANOVA) was used for statistical significance. 
Fig. 4 Effect of cwp22 mutation on cell wall integrity. 
 (A) Triton X-100 autolysis assay. (B) LDH cytotoxicity assay. (C) Percent of dead cells. (D) 
Detection of cell viability. Top panel: images from the bright field; middle panel: images from 
the merged green / red staining with CFDA and PI, respectively; bottom panel: images of TEM 
(80 kv).  Experiments were independently repeated thrice. Bars stand for mean ± SEM, (*P<0.05, 
**P<0.01). Student’s unpaired t-test was used for two groups comparison. One-way analysis of 
variance (ANOVA) was used for comparison of more than two groups. 
Fig. 5 Effect of cwp22 mutation on adhesion of C. difficile vegetative cells and spores. 
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Adhesion ability of vegetative cells and spores of C. difficile were determined on HCT-8 cells. 
Experiments were independently repeated thrice. Bars stand for mean ± SEM, (*P<0.05, 
**P<0.01). One-way analysis of variance (ANOVA) was used for statistical significance.  
Fig. 6 Evaluation of cwp22 mutation on C. difficile virulence in mice.  
(A) Mean relative weight changes. (B) Survival curves. (C) Diarrhea percentages. (D) C. difficile 
in feces. (E) C. difficile in cecum at post challenge day 7. (F) Toxin titer of fecal samples. Bars 
stand for mean ± SEM, (*P<0.05). One-way analysis of variance (ANOVA) was used for 
statistical significance. Animal survivals were analyzed by Kaplan-Meier survival analysis with a 
log-rank test of significance.  
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Table 1. Bacterial strains and plasmids utilized in this study. 
Strain or plasmid Genotype or phenotype Reference 
E. coli DH5α Cloning host NEB 
E. coli HB101  Conjugation donor  (Williams et al., 
1990) 
C. difficile R20291  Clinical isolate; ribotype 027 (Stabler et al., 2009) 
R20291::2601 R20291 2601::EMr This work 
R20291::2601/pMTL84153 R20291::2601 containing empty plasmid pMTL84153 This work 
R20291::2601/pMTL84153-
2601 
R20291 2601gene complemented with pMTL84153-2601 This work 
R20291/pMTL84153 R20291 containing empty plasmid pMTL84153 This work 
Plasmids 
pMTL007C-E2 ClosTron plasmid (ColE1, pCD6, catP) (Heap et al., 2010) 
pMTL007C-E2-2601/1483a pMTL007C-E2 derivative retargeted to 2601(Cwp22) gene  This work 
pMTL84151 E. coli-C. difficile shuttle plasmid (pCD6, catP, ColE1+tra, MCS) (Heap et al., 2009) 
pMTL82153 E. coli-C. difficile shuttle plasmid (pCD6, catP, ColE1+tra, MCS) (Heap et al., 2009) 
pMTL84153 E. coli-C. difficile shuttle plasmid (pCD6, catP, ColE1+tra, 
Pfdx+MCS) 
This work 
pMTL84153-2601 complement vector, pMTL84153 containing 2601 gene This work 
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Supplement files 
Fig. S1 Effect of cwp22 mutation on C. difficile growth. 
(A) C. dificile strains were cultured in BHIS and monitored by measuring OD600 for 48 h. (B) 
Growth ratio plotted into time from 16 to 36 h. (C) Slope of growth ratio from 16 to 36 h. 
Experiments were independently repeated thrice. Bars stand for mean ± SEM, (*P<0.05). One-
way analysis of variance (ANOVA) was used for statistical significance. 
Fig. S2 Effect of cwp22 mutation on C. difficile biofilm formation. 
Biofilm of C. difficile strains were detected at 14 and 72 h, respectively. Briefly, C. difficile 
strains were cultured in 48-well plate with RCM (Reinforced Clostridial Medium) at 37 ℃. After 
24 or 72 h culture, the biofilm at the bottom of well was fixed with 2.5% GA for 30 min, 
followed by dying with 0.25% (w/v) crystal violet for 10 minutes. Then the wells were washed 
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with PBS, followed by addition of acetone to dissolve the crystal violet. The absorbance was 
recorded at OD570. Experiments were independently repeated thrice. Bars stand for mean ± SEM, 
(*P<0.05, **P<0.01). One-way analysis of variance (ANOVA) was used for statistical 
significance. 
Fig. S3 Effect of cwp22 mutation on C. difficile motility. 
C. difficile strains were cultured to an OD600 of 0.8. Then 2 µl of each cultures were penetrated 
into soft BHIS agar (0.175%) plate for swimming analysis, alternatively 2 µl of each cultures 
were dropped onto 0.3% BHIS agar plate for swarming analysis. The swimming assay plates 
were cultured for 24 h and the swarming assay plates were culture for 48 h, respectively. (A) 
Swarming assay. 1: R20291::2601 (15.15 ± 1.2 mm, *P<0.05); 2: R20291::2601/pMTL84153 
(13.94 ± 0.7 mm, *P<0.05); 3: R20291::2601/pMTL84153-2601 (18.18 ± 2.2 mm); 4: R20291 
(19.70 ± 1.6 mm). (B) Swimming assay. 1: R20291::2601 (13.94 ± 2.1 mm, *P<0.05); 2: 
R20291::2601/pMTL84153 (12.73 ± 1.8 mm, *P<0.05); 3: R20291::2601/pMTL84153-2601 
(19.09 ± 0.3 mm); 4: R20291 (22.33 ± 2.9 mm). Experiments were independently repeated thrice. 
(*P<0.05). One-way analysis of variance (ANOVA) was used for statistical significance. 
Fig. S4 Effect of cwp22 mutation on C. difficile spores resistance to heat and ethanol. 
C. difficile spores were collected from 2 weeks Clospore media cultured bacteria and purified 
with a sucrose gradient layer (50%, 45%, 35%, 25%, 10%). To determine spore resistance, 1×106 
spores were treated with ethanol (100% v/v) and heat (65 ℃) for 0 - 6 h at 37 ℃, respectively. 
Spores treated at 0, 0.5, 1, 2, 4, and 6 h were plated on BHIS plates with 0.1% TA. Percentage of 
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spore viability following treatment was calculated as follows: post treated CFU / untreated CFU. 
(A) Spores resistance to heat (65 ℃). (B) Spores resistance to 100   Experiments we  
independently repeated thrice. Bars stand for mean ± SEM. One-way analysis of variance 
(ANOVA) was used for statistical significance. 
Fig. S5 Effect of cwp22 mutation on C. difficile sporulation and germination. 
(A) Sporulation assay. C. difficile strains were cultured in Clospore media for 5 days. Afterwards, 
the CFU/ml of cultures from 24, 48 and 72 h incubation were counted on BHIS plates with 0.1% 
TA to detect sporulation ratios. The sporulation ratio was calculated as CFU (65 ℃ heated) / 
CFU (no heated). (B) Germination assay. The heated purified spores were diluted to an OD600 0f 
1.0 in the germination buffer [10 mM Tris (pH 7.5), 150 mM NaCl, 100 mM glycine, 10 mM TA] 
to detect germination ratio. The value of OD600 was monitored immediately (0 min, t0), and was 
detected once every 2 min (tx) for 20 min at 37 ℃. The germinati      600 
(tx) / OD600 (T0). The boiled spores (red line, 100 ℃, 20 min) were used as a negative control. (C) 
DPA release assay. The heated purified spores were diluted into germination buffer 
supplemented with 800 µM of TbCl3 (Terbium(III) chloride). The DPA released from spores was 
monitored with Multi-Mode Reader (excitation, 270 nm; emission, 545 nm). The boiled spores 
(100 ℃, 20 min) w              
without TA were used as a negative control (green line). Experiments were independently 
repeated thrice. Bars stand for mean ± SEM, (*P<0.05). One-way analysis of variance (ANOVA) 
was used for statistical significance. 
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Fig. S6 Effect of cwp22 mutation on C. difficile transcription of sigD and tcdR.  
(A) tcdR gene transcription analysis. (B) sigD gene transcription analysis. Experiments were 
independently repeated thrice. Bars stand for mean ± SEM, (*P<0.05). One-way analysis of 
variance (ANOVA) was used for statistical significance. 
Fig. S7 Effect of cwp22 mutation on C. difficile transcription of fliC.  
Experiments were independently repeated thrice. Bars stand for mean ± SEM, (*P<0.05). One-
way analysis of variance (ANOVA) was used for statistical significance. 
 
 
 
 
 
 
 
 
 
Table S1. Primers utilized in this study. 
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Primer Sequence (5’ to 3’)  
Re-F CCCGAGCTCATGTTTCTAAAAGAGGGGGA 
Re-R CGCGGATCCAATCTATTTTGCAAGAATATCCA 
1-F TAACGAGTGAAAAAGTACTCAAC 
1- R TACTTTGGCGTGTTTCATTG 
2 -F TGGAGATACATATGGAATACATG 
2- R CATCCAGATACTCTTGCTCCA 
3- F TTCACCTATTCTACCACTT 
3- R CCACATACTTGTCCTATATTAG 
4- F GGCAACTCATCATAGAATAAC 
4- R CAGTAAGTCAAGGCGATTA 
Co-F TCCACCAGAAATATGCTTTCCT 
Co-R GATTGTAGGAAGAAGGGCTGG 
Perm ACGAGTGAAAAAGTACTCAACCA 
tcdA-F GCGGAAATGGTAGAAATG 
tcdA-R ATCAGGTGCTATCAATACTT 
tcdB-F GTATTACCTAATGCTCCAA 
tcdB-R CACCTTCATAGTTATCTCTT 
16s-F CCGTAGTAAGCTCTTGAA 
16s-R TGGTGTTCCTCCTAATATC 
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Table S2. Complementation plasmid maintenance assay. 
Sample Day Plasmid maintain (%) 
  
pMTL84153 pMTL84153-2601 
Strains 
0 100 100 
5 50.12 ± 2.4 * 89.33 ± 3.1 
10 34.26 ± 1.8 * 75.69 ± 2.6 * 
15 16.67 ± 2.1 ** 51.21 ± 2.4 * 
20 9.73 ± 216 ** 49.17 ± 3.4 * 
Feces 
1 90.46 ± 3.1 
2 74.51 ± 1.7 * 
3 41.1 ± 1.6 * 
4 31.65 ± 2.8 * 
5 22.39 ± 2.4 ** 
6 16.67 ± 1.9 ** 
7 14.23 ± 1.6 ** 
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